RNF213 Gene Moyamoya disease type 2, susceptibility to NGS Genetic Test
Short Name: RNF213 Moyamoya Type 2 NGS Test
Also known as: RNF213 Mutation Test, Moyamoya Disease Genetic Test, RNF213 Gene Analysis
RNF213 Gene Moyamoya disease type 2, susceptibility to NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS, Next Generation Sequencing on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last reviewed: September 7, 2026
Overview
The purpose of this test is to identify mutations in the RNF213 gene that increase susceptibility to Moyamoya disease type 2, aiding in diagnosis, risk assessment, and family planning.
- Test Code
- 5334
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- 3 to 4 Weeks
- Fasting Required
- No
- Method
- NGS, Next Generation Sequencing
Sample Collection
No specific preparation required. Ensure genetic counseling session is scheduled to discuss family history and test implications.
Method: Venipuncture
Laboratory Analysis
A small blood sample will be drawn from a vein in the arm using a sterile needle. The procedure is quick and minimally invasive.
Report Delivery
Apply pressure to the puncture site to prevent bleeding. Resume normal activities immediately. Store sample as instructed for stability.
Timeline: 3 to 4 Weeks
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to identify mutations in the RNF213 gene that increase susceptibility to Moyamoya disease type 2, aiding in diagnosis, risk assessment, and family planning.
How to Prepare
- Fast for 4-6 hours if specified by physician
- Avoid strenuous activity before sample collection
- Bring identification and prescription if available
- Inform staff of any medications or health conditions
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"This NGS genetic test is essential for early identification of RNF213 gene mutations, enabling proactive management and family planning for Moyamoya disease type 2."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted samples
- Insufficient sample volume
- Unlabeled or mislabeled containers
- Samples older than stability period
Understanding Your Results
Positive for pathogenic variant
High risk for Moyamoya disease type 2; recommend clinical evaluation and monitoring.
Negative for pathogenic variant
Low genetic risk; consider other diagnostic tests if symptoms persist.
Variant of uncertain significance (VUS)
Further testing and family studies may be needed for clarification.
Likely pathogenic variant
Moderate to high risk; genetic counseling recommended for management.
Consult a doctor if you experience symptoms like headaches, seizures, or neurological deficits, or if you have a family history of Moyamoya disease or stroke.
Limitations
- ⚠May not detect all genetic variants
- ⚠Results may include variants of uncertain significance (VUS)
- ⚠Does not replace clinical diagnosis or imaging tests
- ⚠Limited to RNF213 gene analysis; other Moyamoya-related genes not covered
Risks & Considerations
- ●Minimal risk from blood draw, such as bruising or infection
- ●Psychological impact of genetic results
- ●Potential for inconclusive results requiring further testing
Interfering Factors
- ●Sample contamination
- ●Degraded DNA quality
- ●Recent blood transfusions
- ●Improper sample storage
Compare With Similar Tests
| Test | RNF213 Gene Moyamoya disease type 2, susceptibility to NGS Genetic Test | ACTA2 Gene Test | Comprehensive Moyamoya Panel | Stroke Risk Genetic Panel | Whole Exome Sequencing |
|---|---|---|---|---|---|
| Comparison | RNF213 Gene Moyamoya disease type 2, susceptibility to NGS Genetic Test |
Frequently Asked Questions
What is the RNF213 Gene Moyamoya Disease Type 2 NGS Genetic Test?
Who should consider this genetic test?
How is the test performed?
What is the cost of the test?
Is home sample collection available?
How long does it take to get results?
What do the results mean?
Are there any risks associated with the test?
Can this test diagnose Moyamoya disease?
Is the test covered by insurance?
What should I do before the test?
How accurate is the NGS genetic test?
Related Tests
Angelman Syndrome Test
₹10,000Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test
₹14,000Episodic Ataxia Type 1 Hotspot Test
₹11,500Episodic Ataxia Comprehensive Profile Hotspot Test
₹16,000Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test
₹7,500Analyzer 18 SMA 18 Test Panel
₹1,755Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
